Streetbeat News

Products Services

PFE

SNY

TAK

Pfizer, Sanofi, and Takeda are set to increase prices on over 500 unique drugs in the US in early January, according to data from 3 Axis Advisors reported by Reuters.

Portfolio Pulse from Charles Gross

December 29, 2023 | 2:17 pm

AMTD

HKD

AMTD's film 'The Goldfinger' is set for a global release tomorrow. This could potentially increase visibility and revenue for AMTD, impacting its stock positively in the short term.

Portfolio Pulse from Bill Haddad

December 29, 2023 | 2:17 pm

COIN

Jason Choi, co-founder of Tangent, reviewed 2024 crypto industry predictions from top financial and crypto institutions. He is optimistic about Bitcoin ETFs and Layer 2 technologies but pointed out gaps in areas like Ethereum's future, AI integration, decentralized personal identification, decentralized science, and consumer applications in crypto. Choi's insights included information from Pantera Capital, Binance, Crypto.com, Andreessen Horowitz, VanEck, Bitwise Invest, Hashdex, Fidelity, Messari Crypto, and Coinbase Inc. (NASDAQ:COIN). These gaps may offer new opportunities for growth in the crypto sector.

Portfolio Pulse from Murtuza Merchant

December 29, 2023 | 1:54 pm

FSR

Fisker Inc. (NYSE:FSR) shares are up after a positive December 2023 business update. The company reported a 300% increase in deliveries from Q3 to Q4, with total deliveries around 4,700, primarily of the Fisker Ocean One launch edition. Fisker produced 10,142 Fisker Oceans in 2023 and began customer deliveries in June, with significant numbers in September and October. The company has expanded to 12 markets, opened four flagship Lounges, and plans to announce a sales and delivery acceleration plan in January 2024. Fisker will also increase test-drive events, which have boosted sales. Shares rose 10.6% to $1.67 in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

December 29, 2023 | 1:53 pm

ALNY

ARWR

IBB

LEGN

PIPR

SPY

Piper Sandler Cos has selected Arrowhead Pharmaceuticals, Legend Biotech, and Alnylam Pharmaceuticals as top biotech picks for 2024, predicting a sector comeback. Arrowhead's gene therapies, Legend's Carvykti for bone marrow cancer, and Alnylam's focus on neurological disorders are key highlights. Despite recent share price declines, Piper Sandler forecasts significant share price increases for these companies over the next 12 months. The biotech sector's performance, as tracked by the iShares Biotechnology ETF, has lagged behind the broader market, represented by the SPDR S&P 500 ETF.

Portfolio Pulse from Surbhi Jain

December 29, 2023 | 1:34 pm

AMZN

GOOG

GOOGL

META

MSFT

RJF

Raymond James Financial Inc analyst Josh Beck predicts key winners in the generative artificial intelligence (GenAI) race, with Amazon, Meta Platforms, and Alphabet/Google as likely leaders. Despite GenAI being in early stages, its adoption is growing rapidly, with significant investments from venture capitalists. Amazon has made strides with AWS Neuron and SageMaker, Meta's stock has surged due to AI integration in social platforms, and Alphabet/Google and Microsoft are advancing with Gemini 1.0 and Azure AI Studio, respectively.

Portfolio Pulse from Surbhi Jain

December 29, 2023 | 1:34 pm

AAPL

Apple Inc. (AAPL) is aiming to make its Mac lineup a gaming powerhouse by leveraging its Apple silicon chips, such as the M1, M2, and M3, to enhance gaming performance. The company is providing developers with tools and optimizations to bring more games to the Mac, with the goal of competing in the AAA gaming market. Apple's strategy includes creating a unified hardware platform to simplify game development across its devices, potentially making the Mac a more attractive platform for gamers and developers.

Portfolio Pulse from Sudhanshu Singh

December 29, 2023 | 1:24 pm

NVDA

QQQ

Nvidia Corp (NVDA) has announced the launch of the GeForce RTX 4090 D, a modified gaming chip designed to comply with U.S. export controls for the Chinese market. The chip will be available in January and is 5% slower than the banned RTX 4090, priced at 12,999 yuan ($1,842). Nvidia dominates China's AI chip market but faces competition from domestic firms due to U.S. export curbs. NVDA stock has outperformed the Invesco QQQ Trust, Series 1 (QQQ) year-to-date.

Portfolio Pulse from Anusuya Lahiri

December 29, 2023 | 1:20 pm

BABA

PDD

Alibaba Group Holding Ltd (BABA) and JD.com Inc (JD) are intensifying competition in China's e-commerce sector by adopting a 'refund only' policy for dissatisfied customers, a strategy already in use by Pinduoduo (PDD) since 2021. This policy allows customers to receive refunds for products that do not match descriptions, with JD.com's policy effective from December 29. The move reflects the companies' efforts to remain competitive and attract loyal users in a challenging market. Alibaba's stock rose 3.4% last month, while JD.com's increased by 3.9%, with BABA shares closing higher by 1.48% at $77.24 on Thursday.

Portfolio Pulse from Anusuya Lahiri

December 29, 2023 | 1:16 pm

BFRG

Bullfrog AI Holdings' CEO released a letter to shareholders discussing the progress of their drug candidate, BF-114, for liver disease and obesity. The CEO highlighted a pre-clinical animal study and pointed out the potential of the obesity drug market, which is projected to surpass $77 billion by 2030.

Portfolio Pulse from Benzinga Newsdesk

December 29, 2023 | 1:05 pm